Anlotinib Versus Placebo As Adjuvant Therapy for Completely Resected High-Grade Soft Tissue Sarcomas: Interim Results of a Phase 2, Double-Blinded, Randomized Controlled Trial.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要